Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: AI-Driven Early Detection of Skin Cancer
A clinical trial update announcing recruitment for an AI-driven approach to the early detection of melanoma (skin cancer).
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma [Phase 3]
A Phase 3 trial is evaluating HBI-8000 plus nivolumab versus placebo plus nivolumab in advanced unresectable or metastatic melanoma, includi…
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: A Clinical Study of Intismeran Autogene (V940) Plus Pembrolizumab in People With High-Risk Melanoma (V940-001) [Phase 3]
Phase 3 trial update on Intismeran Autogene (V940) in combination with pembrolizumab for high-risk melanoma (V940-001), with the study curre…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: A Single Arm Trial Evaluating the Efficacy and Safety of EVX-01 in Combination With Pembrolizumab in Adults With Unresectable or Metastatic Melanoma [Phase 2]
A Phase 2 single-arm study is evaluating EVX-01 in combination with pembrolizumab for adults with unresectable or metastatic melanoma; the t…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment
A recruiting trial investigating storage and research use of biospecimens from melanoma patients and clinical testing for assignment of trea…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: PLUG-IN: Pembrolizumab Combined With Enfortumab Vedotin for Advanced Melanoma Patients [Phase 2]
Phase 2 trial evaluating pembrolizumab in combination with enfortumab vedotin for advanced melanoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Naltrexone and Propranolol Combined With Immunotherapy [Phase 1]
This is a Phase 1 clinical trial investigating the combination of naltrexone and propranolol with immunotherapy in patients with advanced me…
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Personalised Immunotherapy Platform
Clinical trial update for a personalised immunotherapy platform; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: Study to Evaluate Impact® as Support to Anti PD1 or Anti PD1 Based Regimen Treatment in Patients With Inoperable Locally Advanced or Metastatic Melanoma [NA]
A clinical trial update describing a study evaluating Impact as a supportive option to anti-PD1 therapy for patients with inoperable locally…
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: Excision of Lymph Node Trial (EXCILYNT) (Mel69) [NA]
This Clinical Trial Update covers the EXCILYNT (Mel69) study evaluating excision of a lymph node in melanoma. The trial is currently recruit…
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: A Community-based Educational Initiative to Raise Awareness of Melanoma and Other Skin Cancers. [NA]
This clinical trial update describes a community-based educational initiative aimed at raising awareness of melanoma and other skin cancers.
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
NCI-sponsored prospective study aims to procure tumor tissue to identify novel therapeutic targets and study the tumor microenvironment; enr…
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: A Study of LN-144 in People With Metastatic Melanoma to the Brain [Phase 1]
Phase 1 clinical trial update for LN-144 in people with metastatic melanoma that has spread to the brain. The study is currently active but …
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: War on Melanoma™ Public Health & Education Campaign [NA]
An ongoing clinical trial for the War on Melanoma Public Health & Education Campaign in melanoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors [Phase 1]
Phase 1 clinical trial evaluating memory-like natural killer cells in combination with nivolumab and relatlimab for advanced or metastatic m…
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases [Phase 2]
Phase 2 study compares encorafenib + binimetinib + nivolumab versus ipilimumab + nivolumab in BRAF-V600 mutation melanoma with brain metasta…
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating the combination of Ulixertinib and Palbociclib in patients with advanced pancreatic cancer and other solid…
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: A Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid Tumors [Phase 1]
Phase 1 trial update evaluating AB248 alone or with pembrolizumab in adults with solid tumors, including non-small cell lung cancer, melanom…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: A Study of NX-1607 in Adults With Advanced Malignancies [Phase 1]
A Phase 1 study evaluating NX-1607 in adults with advanced malignancies is actively recruiting across multiple tumor types, including ovaria…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Combination Immunotherapy Targeting Melanoma [Phase 1, Phase 2]
A phase 1/2 clinical trial of a combination immunotherapy for melanoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain Metastases [Phase 2]
Phase 2 trial assessing a triple combination of relatlimab, nivolumab, and ipilimumab in patients with asymptomatic and symptomatic melanoma…
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: AMT-253 in Patients With Advanced Solid Tumours [Phase 1, Phase 2]
A Phase 1/2 clinical trial of AMT-253 in patients with malignant melanoma and other advanced solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: MELAFERT: Impact of Adjuvant Therapy on FERTility in Patients With Resected MELAnoma at High Risk of Relapse.
A recruiting clinical trial evaluating the impact of adjuvant therapy on fertility in patients with resected high-risk melanoma.
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors [Phase 1]
This update describes a Phase 1 trial of R-5780-01 in combination with PD-1 checkpoint inhibitors for solid tumors, currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid Tumors [Phase 1]
Open-label Phase I trial of Super1 TCR-T therapy targeting NY-ESO-1 in patients with advanced solid tumors, currently recruiting.